Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
LivaNova PLC stock logo
LIVN
LivaNova
$55.43
-1.4%
$49.83
$32.48
$58.91
$3.03B0.96697,350 shs428,841 shs
Penumbra, Inc. stock logo
PEN
Penumbra
$263.58
-3.4%
$252.08
$184.80
$310.00
$10.28B0.45494,996 shs358,923 shs
Solventum Corporation stock logo
SOLV
Solventum
$73.19
-0.3%
$73.09
$60.70
$85.92
$12.69B0.531.08 million shs1.56 million shs
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
€26.21
-0.8%
€24.24
€17.12
€28.00
€7.94B0.55350,355 shs382,748 shs
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
LivaNova PLC stock logo
LIVN
LivaNova
0.00%-3.02%+4.65%+23.56%+15.85%
Penumbra, Inc. stock logo
PEN
Penumbra
0.00%-2.84%+8.12%+4.95%+46.32%
Solventum Corporation stock logo
SOLV
Solventum
0.00%+0.86%+2.55%-1.49%+4.75%
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
0.00%+9.53%+17.21%+9.80%+37.16%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
LivaNova PLC stock logo
LIVN
LivaNova
$55.43
-1.4%
$49.83
$32.48
$58.91
$3.03B0.96697,350 shs428,841 shs
Penumbra, Inc. stock logo
PEN
Penumbra
$263.58
-3.4%
$252.08
$184.80
$310.00
$10.28B0.45494,996 shs358,923 shs
Solventum Corporation stock logo
SOLV
Solventum
$73.19
-0.3%
$73.09
$60.70
$85.92
$12.69B0.531.08 million shs1.56 million shs
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
€26.21
-0.8%
€24.24
€17.12
€28.00
€7.94B0.55350,355 shs382,748 shs
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
LivaNova PLC stock logo
LIVN
LivaNova
0.00%-3.02%+4.65%+23.56%+15.85%
Penumbra, Inc. stock logo
PEN
Penumbra
0.00%-2.84%+8.12%+4.95%+46.32%
Solventum Corporation stock logo
SOLV
Solventum
0.00%+0.86%+2.55%-1.49%+4.75%
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
0.00%+9.53%+17.21%+9.80%+37.16%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
LivaNova PLC stock logo
LIVN
LivaNova
3.00
Buy$59.717.73% Upside
Penumbra, Inc. stock logo
PEN
Penumbra
2.88
Moderate Buy$302.9314.93% Upside
Solventum Corporation stock logo
SOLV
Solventum
2.27
Hold$85.4416.75% Upside
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
2.83
Moderate BuyN/AN/A

Current Analyst Ratings Breakdown

Latest LIVN, SOLV, PEN, and STVN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/15/2025
Solventum Corporation stock logo
SOLV
Solventum
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetEqual Weight$79.00 ➝ $82.00
9/11/2025
Solventum Corporation stock logo
SOLV
Solventum
Jefferies Financial Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageHold$80.00
9/3/2025
LivaNova PLC stock logo
LIVN
LivaNova
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$64.00
9/2/2025
Penumbra, Inc. stock logo
PEN
Penumbra
Evercore ISI
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageOutperform$300.00
8/21/2025
LivaNova PLC stock logo
LIVN
LivaNova
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetEqual Weight$55.00 ➝ $58.00
8/8/2025
Solventum Corporation stock logo
SOLV
Solventum
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetEqual Weight$75.00 ➝ $79.00
8/8/2025
Solventum Corporation stock logo
SOLV
Solventum
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight$87.00 ➝ $94.00
7/31/2025
Penumbra, Inc. stock logo
PEN
Penumbra
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetEqual Weight$260.00 ➝ $266.00
7/30/2025
Penumbra, Inc. stock logo
PEN
Penumbra
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price TargetBuy$300.00 ➝ $310.00
7/30/2025
Penumbra, Inc. stock logo
PEN
Penumbra
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOutperform$330.00 ➝ $325.00
7/30/2025
Penumbra, Inc. stock logo
PEN
Penumbra
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price TargetBuy$330.00 ➝ $335.00
(Data available from 9/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
LivaNova PLC stock logo
LIVN
LivaNova
$1.25B2.41$4.18 per share13.26$24.31 per share2.28
Penumbra, Inc. stock logo
PEN
Penumbra
$1.28B8.03$2.79 per share94.48$29.99 per share8.79
Solventum Corporation stock logo
SOLV
Solventum
$8.25B1.54$9.92 per share7.38$17.13 per share4.27
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
€1.19B6.64€0.75 per share35.00€5.02 per share5.22
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
LivaNova PLC stock logo
LIVN
LivaNova
$63.23M-$3.89N/A17.65N/A-16.13%14.57%6.91%10/29/2025 (Estimated)
Penumbra, Inc. stock logo
PEN
Penumbra
$14.01M$3.7670.1052.612.4611.54%11.55%8.76%10/29/2025 (Estimated)
Solventum Corporation stock logo
SOLV
Solventum
$478M$2.1633.8813.332.994.52%29.93%6.65%11/6/2025 (Estimated)
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
€127.45M€0.5448.5445.192.4911.73%10.34%6.21%N/A

Latest LIVN, SOLV, PEN, and STVN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2025Q2 2025
Solventum Corporation stock logo
SOLV
Solventum
$1.45$1.69+$0.24$0.51$2.12 billion$2.16 billion
8/6/2025Q2 2025
LivaNova PLC stock logo
LIVN
LivaNova
$0.84$1.05+$0.21$0.50$332.20 million$352.50 million
7/29/2025Q2 2025
Penumbra, Inc. stock logo
PEN
Penumbra
$0.81$0.86+$0.05$1.15$327.37 million$339.46 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
LivaNova PLC stock logo
LIVN
LivaNova
N/AN/AN/AN/AN/A
Penumbra, Inc. stock logo
PEN
Penumbra
N/AN/AN/AN/AN/A
Solventum Corporation stock logo
SOLV
Solventum
N/AN/AN/AN/AN/A
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
N/AN/AN/AN/A1 Years
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
LivaNova PLC stock logo
LIVN
LivaNova
0.31
1.29
1.09
Penumbra, Inc. stock logo
PEN
Penumbra
0.02
6.75
4.04
Solventum Corporation stock logo
SOLV
Solventum
2.14
1.22
0.86
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
0.25
1.79
1.22

Institutional Ownership

CompanyInstitutional Ownership
LivaNova PLC stock logo
LIVN
LivaNova
97.64%
Penumbra, Inc. stock logo
PEN
Penumbra
88.88%
Solventum Corporation stock logo
SOLV
Solventum
N/A
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
N/A

Insider Ownership

CompanyInsider Ownership
LivaNova PLC stock logo
LIVN
LivaNova
0.29%
Penumbra, Inc. stock logo
PEN
Penumbra
4.20%
Solventum Corporation stock logo
SOLV
Solventum
0.05%
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
LivaNova PLC stock logo
LIVN
LivaNova
2,90054.60 million54.44 millionOptionable
Penumbra, Inc. stock logo
PEN
Penumbra
4,50039.00 million37.05 millionOptionable
Solventum Corporation stock logo
SOLV
Solventum
22,000173.39 million173.30 millionOptionable
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
5,521302.84 millionN/AOptionable

Recent News About These Companies

USNA vs. STVN: Which Stock Is the Better Value Option?
Stevanato Group (STVN) Gets a Buy from Citi

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
LivaNova stock logo

LivaNova NASDAQ:LIVN

$55.43 -0.79 (-1.41%)
Closing price 04:00 PM Eastern
Extended Trading
$55.42 -0.01 (-0.01%)
As of 04:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

Penumbra stock logo

Penumbra NYSE:PEN

$263.58 -9.16 (-3.36%)
Closing price 03:59 PM Eastern
Extended Trading
$263.30 -0.27 (-0.10%)
As of 06:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

Solventum stock logo

Solventum NYSE:SOLV

$73.18 -0.21 (-0.28%)
Closing price 03:59 PM Eastern
Extended Trading
$73.21 +0.02 (+0.03%)
As of 04:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.

Stevanato Group stock logo

Stevanato Group NYSE:STVN

€26.21 -0.21 (-0.79%)
As of 03:59 PM Eastern

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.